Disease
10 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 10, 2026 · JOURNAL ARTICLE
Zoonoses and Public Health
First large-scale surveillance study of A. cantonensis in Spanish rats; descriptive cross-sectional design with low prevalence and localized findings that establish baseline epidemiology but do not assess clinical outcomes or public health risk quantitatively.
SEP 9, 2026 · JOURNAL ARTICLE
Frontiers in Cellular and Infection Microbiology
A descriptive cross-sectional detection study in a wildlife reservoir with no comparator, control group, or intervention; establishes presence and molecular characterization but cannot quantify epidemiologic role or zoonotic risk.
SEP 8, 2026 · REVIEW
Frontiers in Public Health
Systematic review of outbreak data from heterogeneous sources with substantial methodological limitations, underreporting, and inconsistent diagnostic practices; descriptive findings without controlled comparisons or intervention trials.
SEP 7, 2026 · JOURNAL ARTICLE
Cells
Mechanistic in vitro study in cell lines identifying a pathway by which ivermectin may affect stress granule clearance; does not test clinical efficacy or measure patient-relevant outcomes.
SEP 2, 2026 · JOURNAL ARTICLE
Ip International Journal of Medical Microbiology and Tropical Diseases
A comprehensive narrative review synthesizing existing knowledge on Nipah virus biology, epidemiology, and public health response, offering expert recommendations for coordinated One Health policies rather than reporting original research findings.
AUG 30, 2026 · JOURNAL ARTICLE
Japanese Journal of Infectious Diseases
Year-round prospective surveillance describing epidemiology, clinical features, and biomarkers in a single-country, multi-site setting with confirmed dengue cases and serotype characterization, but limited generalizability and no intervention trial or hard clinical outcome comparison.
AUG 16, 2026 · JOURNAL ARTICLE
Advances in Clinical Medical Research
A cross-sectional molecular epidemiology study with confirmed RT-PCR diagnosis linking DENV-2 predominance to severe dengue via multivariate logistic regression, but limited by single-centre design and modest sample size of confirmed cases.
AUG 16, 2026 · JOURNAL ARTICLE
Advances in Clinical Medical Research
A single-centre cross-sectional molecular epidemiology study identifying DENV-2 as predominant and associated with severe dengue (OR 2.91, p=0.009), with clear serotype distribution and clinical correlates, but limited by observational design and modest sample size.